Your browser doesn't support javascript.
loading
A Phase 3, randomized, non-inferiority study of a heterologous booster dose of SARS CoV-2 recombinant spike protein vaccine in adults.
Kulkarni, Prasad S; Gunale, Bhagwat; Kohli, Sunil; Lalwani, Sanjay; Tripathy, Srikanth; Kar, Sonali; Raut, Sidram; Kulkarni, Praveen; Apte, Aditi; Bavdekar, Ashish; Bhalla, Hira Lal; Plested, Joyce S; Cloney-Clark, Shane; Zhu, MingZhu; Kalkeri, Raj; Pryor, Melinda; Hamilton, Stephanie; Thakar, Madhuri; Sannidhi, Ranga S; Baranwal, Punjita; Bhamare, Chetanraj; Dharmadhikari, Abhijeet; Gupta, Manish; Poonawalla, Cyrus S; Shaligram, Umesh; Kapse, Dhananjay.
Affiliation
  • Kulkarni PS; Serum Institute of India Pvt Ltd, Manjari (Bk), Administration Building, Poonawalla Biotechnology Park SEZ, Taluka Haveli, Pune, India. drpsk@seruminstitute.com.
  • Gunale B; Serum Institute of India Pvt Ltd, Manjari (Bk), Administration Building, Poonawalla Biotechnology Park SEZ, Taluka Haveli, Pune, India.
  • Kohli S; Hamdard Institute of Medical Sciences and Research, New Delhi, India.
  • Lalwani S; Bharati Vidyapeeth Deemed University Medical College and Hospital, Pune, India.
  • Tripathy S; Dr. D. Y. Patil Medical College, Hospital and Research Centre, Pune, India.
  • Kar S; Kalinga Institute of Medical Sciences, Bhubaneswar, India.
  • Raut S; Noble Hospital Pvt. Ltd, Pune, India.
  • Kulkarni P; JSS Academy of Higher Education and Research, Mysore, India.
  • Apte A; KEM Hospital Research Centre-Community Health Research Unit, P.O. Manchar, Pune, India.
  • Bavdekar A; KEM Hospital Research Centre-Community Health Research Unit, P.O. Manchar, Pune, India.
  • Bhalla HL; All India Institute of Medical Sciences (AIIMS), Gorakhpur, India.
  • Plested JS; Novavax, Inc., Gaithersburg, USA.
  • Cloney-Clark S; Novavax, Inc., Gaithersburg, USA.
  • Zhu M; Novavax, Inc., Gaithersburg, USA.
  • Kalkeri R; Novavax, Inc., Gaithersburg, USA.
  • Pryor M; 360Biolabs, Melbourne, Australia.
  • Hamilton S; 360Biolabs, Melbourne, Australia.
  • Thakar M; ICMR - National AIDS Research Institute, Pune, India.
  • Sannidhi RS; PPD, Benguluru, India.
  • Baranwal P; PPD, Benguluru, India.
  • Bhamare C; Serum Institute of India Pvt Ltd, Manjari (Bk), Administration Building, Poonawalla Biotechnology Park SEZ, Taluka Haveli, Pune, India.
  • Dharmadhikari A; Serum Institute of India Pvt Ltd, Manjari (Bk), Administration Building, Poonawalla Biotechnology Park SEZ, Taluka Haveli, Pune, India.
  • Gupta M; Serum Institute of India Pvt Ltd, Manjari (Bk), Administration Building, Poonawalla Biotechnology Park SEZ, Taluka Haveli, Pune, India.
  • Poonawalla CS; Serum Institute of India Pvt Ltd, Manjari (Bk), Administration Building, Poonawalla Biotechnology Park SEZ, Taluka Haveli, Pune, India.
  • Shaligram U; Serum Institute of India Pvt Ltd, Manjari (Bk), Administration Building, Poonawalla Biotechnology Park SEZ, Taluka Haveli, Pune, India.
  • Kapse D; Serum Institute of India Pvt Ltd, Manjari (Bk), Administration Building, Poonawalla Biotechnology Park SEZ, Taluka Haveli, Pune, India.
Sci Rep ; 13(1): 16579, 2023 10 03.
Article in En | MEDLINE | ID: mdl-37789040
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Clinical_trials Limits: Adult / Humans Language: En Journal: Sci Rep Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Clinical_trials Limits: Adult / Humans Language: En Journal: Sci Rep Year: 2023 Document type: Article Affiliation country: Country of publication: